235 related articles for article (PubMed ID: 1645269)
61. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
Karp DR; Long EO
J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
[TBL] [Abstract][Full Text] [Related]
62. Superantigens: interaction of staphylococcal enterotoxins with MHC class II molecules.
Rich RR; Mollick JA; Cook RG
Trans Am Clin Climatol Assoc; 1990; 101():195-204; discussion 204-6. PubMed ID: 2577245
[TBL] [Abstract][Full Text] [Related]
63. Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins.
Karp DR; Jenkins RN; Long EO
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9657-61. PubMed ID: 1409679
[TBL] [Abstract][Full Text] [Related]
64. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.
Scholl P; Diez A; Mourad W; Parsonnet J; Geha RS; Chatila T
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4210-4. PubMed ID: 2542966
[TBL] [Abstract][Full Text] [Related]
65. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.
Newton DW; Dohlsten M; Lando PA; Kalland T; Olsson C; Kotb M
Int J Mol Med; 1998 Jan; 1(1):157-62. PubMed ID: 9852214
[TBL] [Abstract][Full Text] [Related]
66. Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor.
Hewitt CR; Lamb JR; Hayball J; Hill M; Owen MJ; O'Hehir RE
J Exp Med; 1992 Jun; 175(6):1493-9. PubMed ID: 1588277
[TBL] [Abstract][Full Text] [Related]
67. Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM.
Lavoie PM; Thibodeau J; Cloutier I; Busch R; Sékaly RP
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6892-7. PubMed ID: 9192662
[TBL] [Abstract][Full Text] [Related]
68. In vivo staphylococcal superantigen-driven polyclonal Ig responses in mice: dependence upon CD4(+) cells and human MHC class II.
Stohl W; Xu D; Zang S; Kim KS; Li L; Hanson JA; Stohlman SA; David CS; Jacob CO
Int Immunol; 2001 Oct; 13(10):1291-300. PubMed ID: 11581174
[TBL] [Abstract][Full Text] [Related]
69. Class II MHC molecules are specific receptors for staphylococcus enterotoxin A.
Mollick JA; Cook RG; Rich RR
Science; 1989 May; 244(4906):817-20. PubMed ID: 2658055
[TBL] [Abstract][Full Text] [Related]
70. Site of nonrestrictive binding of SEA to class II MHC antigens.
Pontzer CH; Russell JK; Jarpe MA; Johnson HM
Int Arch Allergy Appl Immunol; 1990; 93(2-3):107-12. PubMed ID: 2099338
[TBL] [Abstract][Full Text] [Related]
71. Ligation of MHC class II molecules differentially upregulates TNF beta gene expression in B cell lines of different MHC class II haplotypes.
Guo W; Mourad W; Charron D; Al-Daccak R
Hum Immunol; 1999 Apr; 60(4):312-22. PubMed ID: 10363722
[TBL] [Abstract][Full Text] [Related]
72. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens.
Labrecque N; Thibodeau J; Mourad W; Sékaly RP
J Exp Med; 1994 Nov; 180(5):1921-9. PubMed ID: 7964467
[TBL] [Abstract][Full Text] [Related]
73. Interferon gamma-treated keratinocytes activate T cells in the presence of superantigens: involvement of major histocompatibility complex class II molecules.
Strange P; Skov L; Baadsgaard O
J Invest Dermatol; 1994 Feb; 102(2):150-4. PubMed ID: 7906285
[TBL] [Abstract][Full Text] [Related]
74. Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.
Dohlsten M; Abrahmsén L; Björk P; Lando PA; Hedlund G; Forsberg G; Brodin T; Gascoigne NR; Förberg C; Lind P
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8945-9. PubMed ID: 8090750
[TBL] [Abstract][Full Text] [Related]
75. Direct binding of secreted T-cell receptor beta chain to superantigen associated with class II major histocompatibility complex protein.
Gascoigne NR; Ames KT
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):613-6. PubMed ID: 1824876
[TBL] [Abstract][Full Text] [Related]
76. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes.
Phillips JH; Gumperz JE; Parham P; Lanier LL
Science; 1995 Apr; 268(5209):403-5. PubMed ID: 7716542
[TBL] [Abstract][Full Text] [Related]
77. MHC class II positive retinal pigment epithelial (RPE) cells can function as antigen-presenting cells for microbial superantigen.
Osusky R; Dorio RJ; Arora YK; Ryan SJ; Walker SM
Ocul Immunol Inflamm; 1997 Mar; 5(1):43-50. PubMed ID: 9145692
[TBL] [Abstract][Full Text] [Related]
78. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells.
Herman A; Croteau G; Sekaly RP; Kappler J; Marrack P
J Exp Med; 1990 Sep; 172(3):709-17. PubMed ID: 2117633
[TBL] [Abstract][Full Text] [Related]
79. Bacterial superantigen signaling via HLA class II on human B lymphocytes.
Mooney NA; Ju L; Brick-Ghannam C; Charron DJ
Mol Immunol; 1994 Jun; 31(9):675-81. PubMed ID: 8028602
[TBL] [Abstract][Full Text] [Related]
80. Major histocompatibility complex class I molecule serves as a ligand for presentation of the superantigen staphylococcal enterotoxin B to T cells.
Häffner AC; Zepter K; Elmets CA
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3037-42. PubMed ID: 8610164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
